United States · FDA National Drug Code directory
SIMBRINZA
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0065-4147_889225d1-6257-4b32-b9cc-5f9c459c994a
- Product NDC
- 0065-4147
- Form
- SUSPENSION/ DROPS
- Composition / generic term
- brinzolamide/brimonidine tartrate
- Labeler
- Alcon Laboratories, Inc.
- Marketing category
- NDA
- Marketing start / end (source format)
- 20130506
- Source listing expiry
- 20261231
Source-listed ingredients
- BRINZOLAMIDE — 10 mg/mL
- BRIMONIDINE TARTRATE — 2 mg/mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE, DROPPER in 1 CARTON (0065-4147-25) / 2.5 mL in 1 BOTTLE, DROPPER · 0065-4147-25
- 1 BOTTLE, DROPPER in 1 CARTON (0065-4147-27) / 8 mL in 1 BOTTLE, DROPPER · 0065-4147-27
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →